This guide explains how semaglutide works, who it tends to help most, who should avoid it, how to pair it with nutrition and strength training for better results, and what to expect during the first year
MHRA data (as of June 2025) links GLP1 agonists to: 181 pancreatitis cases for Mounjaro (5 deaths) 113 cases for Wegovy/Ozempic (1 death) 82 total deaths (22 weight loss
Comfort: Some areas may be more sensitive or prone to bruising
Realistischer Zulassungszeitplan: Frhestmgliche NDA-Einreichung Q4 2026, FDA-Entscheidung 2027 oder spter, EMA typischerweise 6 bis 12 Monate dahinter, CVOT-Daten ab 2028 bis 2029
Disclaimer: This article is for educational purposes only and does not replace medical advice
It will speed up your metabolism, elevate your mood, and boost your energy